Medtronic (MDT): Rep. Michael Guest (MS03) disclosed a purchase $1K–$15K
Rep. Michael Guest (MS03) disclosed a purchase of Medtronic in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 16 days
- Disclosure lag
- Traded
- Aug 7, 2023
- Disclosed
- Aug 23, 2023
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 15, 2023CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Aug 7, 2023 · this disclosureCongressDisclosed purchase of MDT — reported range $1,001 - $15,000
What came next
- Sep 21, 2023CongressDisclosed sale of MDT — reported range $50,001 - $100,000
- Sep 26, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Oct 24, 2023CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Oct 27, 2023FDAFDA device clearance: GIA Stapler with Tri-Staple Technology
- Oct 31, 2023FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (LNQ22)
- Oct 31, 2023FDAFDA device clearance: FlexCath Contour Steerable Sheath
- Nov 3, 2023FDARecall: ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac Monitor
- Nov 7, 2023FDARecall: NIM TriVantage EMG Endotracheal Tubes, Model (REF) Numbers and sizes: a) 8229706, 6.0MM ID; b) 8229707, 7.0MM ID; c) 8229708, 8.0MM ID; d) 8229736, 6MM ID 3PK;…
- Nov 13, 2023FDARecall: Medtronic SynchroMed II, Model 8637-20, Programmable pump
- Nov 13, 2023FDARecall: Medtronic SynchroMed II, Model 8637-40, Programmable pump
- Nov 15, 2023FDARecall: Guardian 4 Glucose Sensor, REF: MMT-7040A, MMT-7040C1, MMT-7040C2, MMT-7040C3, MMT-7040D1, MMT-7040D2, MMT-7040MA, MMT-7040QC1, MMT-7040QC2, MMT-7040QC3
- Nov 16, 2023FDARecall: AbsorbaTack Absorbable Fixation Device 30 Violet Absorbable Tacks 5 mm- -intended for fixation of prosthetic material to soft tissue in minimally invasive and…
- Nov 16, 2023FDARecall: Covidien Valleylab FT10, FT Series Energy Platform, REF: VLFT10GEN, DLVLFT10GEN, VLFT10GENZD
- Nov 17, 2023FDAFDA device approval: Symplicity Spyral Renal Denervation System
- Nov 20, 2023FDARecall: Protege GPS Self-Expanding Peripheral Stent System, product number SERB65-09-60-80, Sterile.
- Nov 28, 2023FDARecall: Medtronic, REF 9733235, Pin, 100mm, STERILE, PERCUTANEOUS
- Nov 28, 2023FDARecall: Medtronic, REF 9733236, Pin, 150mm, STERILE, PERCUTANEOUS
- Dec 2, 2023FDAFDA device clearance: Cosine-10TM Diagnostic Catheter
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 40 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
Other recent filings by Rep. Michael Guest (MS03)
- House Clerk periodic transaction report at Airbnb (ABNB)Aug 14, 2026
- House Clerk periodic transaction report at Chevron (CVX)Aug 14, 2026
- House Clerk periodic transaction report at e.l.f. Beauty (ELF)Aug 14, 2026
- House Clerk periodic transaction report at Exxon Mobil (XOM)Aug 14, 2026
- House Clerk periodic transaction report at Exxon Mobil (XOM)Aug 14, 2026
The full history of Rep. Michael Guest (MS03) is on the profile page.
How this filing works
Explore the data
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
